Similar Papers

Paper Title
Journal
Date
Author
TRAIL Resistance of Breast Cancer Cells Is Associated with Constitutive Endocytosis of Death Receptors 4 and 5
Yaqin Zhang ... Baolin Zhang
Molecular Cancer Research | VOL. 6
Yaqin Zhang, et. al.Yaqin Zhang ... Baolin Zhang
01 Dec 2008
Data from TRAIL Resistance of Breast Cancer Cells Is Associated with Constitutive Endocytosis of Death Receptors 4 and 5
Yaqin Zhang ... Baolin Zhang
-
Yaqin Zhang, et. al.Yaqin Zhang ... Baolin Zhang
03 Apr 2023
Data from TRAIL Resistance of Breast Cancer Cells Is Associated with Constitutive Endocytosis of Death Receptors 4 and 5
Yaqin Zhang ... Baolin Zhang
-
Yaqin Zhang, et. al.Yaqin Zhang ... Baolin Zhang
03 Apr 2023
Real-time imaging of the dynamics of death receptors and therapeutics that overcome TRAIL resistance in tumors
T Bagci-Onder ... P Sorger
Oncogene | VOL. 32
T Bagci-Onder, et. al.T Bagci-Onder ... P Sorger
23 Jul 2012
View more papers

More From: Neuro-oncology

Paper Title
Journal
Date
Author
Loss of LDOC1 by chromatin compaction in mesenchymal tumor cells is required for PFA1 ependymoma growth.
Graziella Ribeiro De Sousa ... Andrea M Griesinger
Neuro-oncology | VOL. -
Graziella Ribeiro De Sousa, et. al.Graziella Ribeiro De Sousa ... Andrea M Griesinger
04 Feb 2025
Molecular subtypes of adamantinomatous craniopharyngiomas.
Wenhao An ... Zhixiong Lin
Neuro-oncology | VOL. -
Wenhao An, et. al.Wenhao An ... Zhixiong Lin
03 Feb 2025
Intrathecal Sintilimab for Leptomeningeal Metastases of Non-small Cell Lung Cancer Failed from Targeted Therapy and Intrathecal Chemotherapy (LMIS study).
Chengjuan Fan ... Tao Xin
Neuro-oncology | VOL. -
Chengjuan Fan, et. al.Chengjuan Fan ... Tao Xin
03 Feb 2025
GBMPurity: A Machine Learning Tool for Estimating Glioblastoma Tumour Purity from Bulk RNA-seq Data.
Morgan P H Thomas ... Lucy F Stead
Neuro-oncology | VOL. -
Morgan P H Thomas, et. al.Morgan P H Thomas ... Lucy F Stead
01 Feb 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.